Donald Trump has been popping up in the comic strip "Doonesbury" since the 1980s. Now, author Garry Trudeau has compiled his satire into a new book. The cartoonist looks back on thirty years of drawing Donald Trump.
Macular degeneration is one of the most common causes of blindness in older Americans. Between 10 million and 15 million people in the U.S. have some form of the eye disease. As baby boomers age, doctors expect those numbers to climb sharply. There is no cure, but early diagnosis and treatment can help slow the progression of the disease. A limited number of people have had success improving their vision with the aid of a tiny telescope implanted behind the iris. Others receive drug injections directly into the eye. And there’s promising work being done in stem cell research. Experts talk about the latest in treating macular degeneration.
- Jim Hindman founder of Jiffy Lube and author of "Was Blind, But Now I See: Life Stories (and Lessons) in My Fight against Age-Related Macular Degeneration."
- Dr. Judith Goldstein director of Vision Rehabilitation Services at the Wilmer Eye Institute, Johns Hopkins University; assistant professor of Ophthalmology and Rehabilitation Medicine, Johns Hopkins University.
- Dr. Julia Haller ophthalmologist-in-chief of the Wills Eye Hospital in Philadelphia and one of the nation's leading retina surgeons and researchers.
Most Recent Shows
The new CEO of Donald Trump’s campaign is closely aligned with the so-called “alt-right,” a nationalist movement that rejects multiculturalism. The rise of the alt-right movement and its place in this year’s presidential campaign.
Italy searches for survivors after a devastating earthquake. Turkey escalates its role in the fight against ISIS. And Colombia and the FARC rebels sign a peace treaty ending a half-century-long guerrilla war. A panel of journalists joins guest host Derek McGinty for analysis of the week's top international news stories.
Donald Trump signals a shift in his stance on immigration. After another batch of emails, The Clinton Foundation says it will make changes if Hillary Clinton becomes president. And outrage over the skyrocketing cost of the EpiPen. A panel of journalists joins guest host Derek McGinty for analysis of the week's top national news stories.